(Q39504404)

12 September 2017

Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study (English)

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

multicenter clinical trial

10 November 2022

main subject

placebo

0 references

0 references

1 reference

1 reference

McCullough A

7

1 reference

12 September 2017

S. J. Sontag

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727744

10 November 2022

B. I. Hirschowitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727744

10 November 2022

S. Holt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727744

10 November 2022

M. G. Robinson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727744

10 November 2022

J. Behar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727744

10 November 2022

M. M. Berenson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727744

10 November 2022

A. McCullough

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727744

10 November 2022

A. F. Ippoliti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727744

10 November 2022

J. E. Richter

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727744

10 November 2022

G. Ahtaridis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727744

10 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

full work available at URL

12 September 2017

http://api.elsevier.com/content/article/PII:001650859291790B?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

http://api.elsevier.com/content/article/PII:001650859291790B?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

10 November 2022

1 reference

12 September 2017

102

1 reference

12 September 2017

109-118

1 reference

12 September 2017

1

1 reference

Why do apparently healthy people use antacid tablets?

12 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Symptomatic gastroesophageal reflux: incidence and precipitating factors

10 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects

10 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Mechanisms of gastroesophageal reflux in patients with reflux esophagitis

10 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Oesophageal acid clearing: one factor in the production of reflux oesophagitis

10 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Acid clearance during sleep in the pathogenesis of reflux esophagitis

10 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Role of bile and pancreatic juice in production of esophageal erosions and anemia

10 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Subacute Erosive (Peptic) Esophagitis Associated with Achlorhydria

10 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Patterns of Gastroesophageal Reflux in Health and Disease

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease

10 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Statistical aspects of the analysis of data from retrospective studies of disease

10 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Evaluation of survival data and two new rank order statistics arising in its consideration

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

10 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

10 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study

10 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis

10 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis

10 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial

10 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0016-5085(92)91790-B

10 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1727744

10 November 2022

1 reference